Analyst upgrades: PETS, MSPDD and QLGC

Posted Jul 22nd 2008 11:24AM by Eric Buscemi
Filed under: Analyst upgrades and downgrades

MOST NOTEWORTHY: PetMed Express, Mindspeed and QLogic were today's noteworthy upgrades:

• Piper upgraded shares of PetMed Express (NASDAQ: PETS) to Neutral from Sell after the company's Q1 results topped estimates on strong new customer growth. Piper raised their target to $14 from $11.
  
• Oppenheimer raised Mindspeed (NASDAQ: MSPDD) to Outperform from Perform following the Q3 results, as they believe the company is hitting its stride in VoIP after years of investment and the stock is attractively valued.
  
• Citigroup upgraded QLogic (NASDAQ: QLGC) shares to Buy from Hold following the company's Q1 results and Brocade (NASDAQ: BRCD)'s acquisition of Foundry Networks, Inc. (NASDAQ: FDRY) to reflect its solid fundamentals and the strategic significance of its switch business. The firm raised their target to $20 from $18.

OTHER UPGRADES:

• Goldman added Amylin Pharma (NASDAQ: AMLN) to the Conviction Buy List.
  
• Cleco (NYSE: CNL) was raised to Buy from Hold at Soleil.
  
• Canadian National Oil (NYSE: CNI) was upgraded at TD Newcrest to Buy from Hold.

Tags: amln, brcd, cni, cnl, fdry, mspdd, pets, qlgc